We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Resistance to phagocytosis: key complement components
- Destruction of host chemotactic signals impedes recruitment of PMNs to sites of infection
- C5a peptidase: specific destruction of C5a chemotaxin
- Human C5a
- M protein
- M protein – promotes resistance to phagocytosis and intracellular invasion
- Superantigens
- Tonsils are reservoir for recurrent infection
- S. pyogenes enter tonsils through M cells scattered along epithelium
- S. pyogenes uses multiple adhesins and invasins to manipulate the host cell cytoskeleton
- Ingestion by host cells is varied and streptococcal strain dependent
- S. pyogenes induces robust cytokine TGFß1 expression in lymphoid tissue
- S. pyogenes survive and multiply within professional phagocytes
- Intranasal S. pyogenes infection induces TGFß1 and IL-6, promoting Th17 immunity
- Broader implications
- Summary
- Financial disclosures
Topics Covered
- S. pyogenes
- Resistance to phagocytosis
- C5a peptidase
- Human C5a
- M protein
- Superantigens
- Adhesins and invasins
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Cleary, P.P. (2026, March 31). Streptococcus pyogenes: disease and molecular pathogenesis 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 3, 2026, from https://doi.org/10.69645/CQXI2573.Export Citation (RIS)
Publication History
- Published on March 31, 2026
Financial Disclosures
- Dr. Cleary and the University of Minnesota receive an annual fee for licensing the patent of his invention of vaccines for prevention of S. pyogenes and S. agalactiae infections that are in early phase developments by Pfizer Inc.
Streptococcus pyogenes: disease and molecular pathogenesis 2
Published on March 31, 2026
33 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:05
I'd like to briefly review
the complement pathway.
It's so important
for understanding
the pathogenesis of
Streptococcus pyogenes
and actually quite a few
other bacterial pathogens.
In a non-immune animal,
the alternative pathway
is critical for providing
effector molecules that
remove bacteria from tissue.
In an immune animal, the
classical pathway is
activated by
antibody-antigen reactions.
There are several important
molecules generated by
the proteolytic cleavage of
complement proteins
in our blood.
One of the most
important is C3b.
It's an opsonin.
It butters up bacteria so
they can be recognized by
complement receptors
on phagocytic cells.
C5a is the chemotaxin
that attracts
phagocytes such as PMNs or
macrophages very early
in an infection.
Obviously, both of
these molecules are
critical for removing
bacteria from tissues.
If the bacterium is a
gram-negative bacterium,
the complement system
ultimately produces
a complex called the
membrane attack complex.
This inserts holes in
the outer membrane of
gram-negative bacteria.
The membrane attack complex has
really no effect on
gram-positive bacteria,
which lack an outer membrane.
1:32
As I stated, C5a is
an important product of
the complement activation.
It's the earliest
signal to attract
phagocytic cells to
a site of infection.
IL8 is another chemotaxin
that's important.
It's produced somewhat
later by inflammation.
Both chemotaxins recruit
PMNs and macrophages locally
to clean up foreign microbes
before infection progresses.
The C5a peptidase
or SCPA is produced
by all M types of S. Pyogenes
and human isolates of
Streptococcus agalactiae,
group C streptococci, and
group G streptococci.
Cow, pig, and horse isolates
genetically lack the protease.
S. Pneumoniae also produces
a related but
different protease.
Strep also produces
an IL8-specific
protease called SpyCEP.
It's not produced by all
M types of S. Pyogenes.
Both proteins are
highly conserved,
and both are candidates
for vaccine development.
The reference listed on
the slide by McKenna is
an in-depth review
of the biochemistry
and the role of these
proteases in infection.